发明名称 |
Pyrimidine and purine derivatives and their use in treating tumour cells |
摘要 |
The present invention provides certain 6-hetarylalkyloxy pyrimidine derivatives of formula II wherein R is (i) a cyclic group having at least one 5- or 6-membered heterocyclic ring, optionally with a carbocyclic or heterocyclic ring fused thereto, the or each heterocyclic ring having at least one hetero atom chosen from O, N, or S, or a substituted derivative thereof; or (ii) phenyl or a substituted derivative thereof, R2 is selected from H, C1-C5 alkyl, halogen or NH2, R4 and R5 which are the same or different are selected from H, NH2 or NOn where n=1 or 2, or R4 and R5 together with the pyrimidine ring form a 5-or 6-membered ring structure containing one or more heterocyclic atoms, and pharmaceutically acceptable salts thereof, exhibit the ability to deplete +E,uns O+EE 6-alkylguanine-DNA alkyltransferase (ATase) activity.
|
申请公布号 |
US5929046(A) |
申请公布日期 |
1999.07.27 |
申请号 |
US19950572966 |
申请日期 |
1995.12.15 |
申请人 |
CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED |
发明人 |
MCMURRY, THOMAS BRIAN HAMILTON;MCELHINNEY, ROBERT STANLEY;DONNELLY, DOROTHY JOSEPHINE;MURRAY, PAUL;CAROLA, CHRISTOPHE;ELDER, RHODERICK HUGH;KELLY, JANE;MARGISON, GEOFFREY PAUL;RAFFERTY, JOSEPH ANTHONY;WATSON, AMANDA JEAN;WILLINGTON, MARK ANDREW |
分类号 |
C07D239/47;A61K31/00;A61K31/17;A61K31/505;A61K31/519;A61K31/52;A61K31/522;A61K31/529;A61K31/70;A61K31/7042;A61K31/7052;A61K31/706;A61K31/7064;A61K31/7076;A61K31/708;A61P35/00;A61P43/00;C07D239/46;C07D239/48;C07D401/12;C07D405/12;C07D409/12;C07D471/04;C07D473/00;C07D473/18;C07D473/22;C07D473/30;C07D473/40;C07D475/02;C07D475/04;C07D487/04;C07D498/04;C07D513/04;C07H19/04;C07H19/06;C07H19/16;C07H19/167;C07H19/173;C07H19/19;C07H19/23;(IPC1-7):A61K31/70 |
主分类号 |
C07D239/47 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|